RILUZOLE ZENTIVA 50 mg, film-coated tablet 56 tablets
Active ingredients: Riluzole
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RILUZOLE ZENTIVA 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) thermoformée(s) PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- ZENTIVA (REPUBLIQUE TCHEQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62414855CIP72242500CIP133400922425009Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RILUZOLEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.